pubmed-article:21069358 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21069358 | lifeskim:mentions | umls-concept:C1366557 | lld:lifeskim |
pubmed-article:21069358 | lifeskim:mentions | umls-concept:C1704256 | lld:lifeskim |
pubmed-article:21069358 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:21069358 | lifeskim:mentions | umls-concept:C0018802 | lld:lifeskim |
pubmed-article:21069358 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:21069358 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:21069358 | pubmed:dateCreated | 2011-3-24 | lld:pubmed |
pubmed-article:21069358 | pubmed:abstractText | Atrial fibrillation (AF) and acute congestive heart failure (aCHF) are characterized by an adverse cardiac remodeling. Arrhythmogenic or structural remodeling can be caused by interstitial fibrosis. Transforming growth factor beta 1 (TGF-beta 1) represents a central regulator of cardiac fibrosis. This study investigates serum levels of TGF-beta 1 in patients with AF and aCHF. | lld:pubmed |
pubmed-article:21069358 | pubmed:language | eng | lld:pubmed |
pubmed-article:21069358 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21069358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21069358 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21069358 | pubmed:month | Apr | lld:pubmed |
pubmed-article:21069358 | pubmed:issn | 1861-0692 | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:BorggrefeMart... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:Ahmad-NejadPa... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:BrueckmannMar... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:LangSiegfried... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:NeumaierMicha... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:HoffmannUrsul... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:WeissChristel... | lld:pubmed |
pubmed-article:21069358 | pubmed:author | pubmed-author:BehnesMichael... | lld:pubmed |
pubmed-article:21069358 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21069358 | pubmed:volume | 100 | lld:pubmed |
pubmed-article:21069358 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21069358 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21069358 | pubmed:pagination | 335-42 | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:meshHeading | pubmed-meshheading:21069358... | lld:pubmed |
pubmed-article:21069358 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21069358 | pubmed:articleTitle | Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure. | lld:pubmed |
pubmed-article:21069358 | pubmed:affiliation | First Department of Medicine, University Medical Centre Mannheim, Medical Faculty of Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim, Germany. michael.behnes@umm.de | lld:pubmed |
pubmed-article:21069358 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21069358 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:21069358 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21069358 | lld:pubmed |